Johnson & Johnson and its McNeil unit have agreed to a confidential settlement with individuals alleging Tylenol caused liver damage, according to Feb. 10 filings (In re Tylenol (Acetaminophen) Mktg., Sales Prac. & Prod. Liab. Litig., E.D. Pa., No. 13-2436, motion filed 2/10/17).
Plaintiffs nationally alleged that use of Tylenol at or just above the recommended dose could cause liver injury and, in some instances, death.
McNeil Consumer Healthcare, which distributes Tylenol, said it has entered into a settlement that “should effectively ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.